查詢結果分析
相關文獻
- Local Regional Relapse Patterns Following Ipsilateral Postoperative Adjuvant Radiotherapy for Buccal Cancer
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- Radiation Therapy in Primary Central Nervous System Lymphoma
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 攝護腺癌之傳統放射線治療--長庚紀念醫院十四年之經驗
- Preoperative Radiotherapy in Patients with Lower Rectal Cancer:Results of Sphincter-Preservation, Treatment Outcome and Morbidities
- A Phase Ⅱ Study of Neoadjuvant Interferon Alfa-2B and Concurrent Interferon and Radiotherapy in Primary Untreated Undifferentiated Carcinoma of Nasopharynx
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- The Role of Radiotherapy for Advanced Non-Small Cell Lung Cancer
頁籤選單縮合
題 名 | Local Regional Relapse Patterns Following Ipsilateral Postoperative Adjuvant Radiotherapy for Buccal Cancer=頰癌病患接受同側術後輔助性放療之局部復發情形探討 |
---|---|
作 者 | 簡君儒; 丁禮莉; 鍾娜娜; 雷德; | 書刊名 | 中華放射線醫學雜誌 |
卷 期 | 28:1 2003.02[民92.02] |
頁 次 | 頁9-15 |
分類號 | 416.36 |
關鍵詞 | 頰鱗狀細胞癌; 腫瘤局部復發; 放射治療; Buccal carcinoma; Local recurrence; Radiotherapy; |
語 文 | 英文(English) |
中文摘要 | 研究頰癌經同側術後輔助性放療之局部復發模式,以協助決定術後輔助性放療之適當靶體積。 自1991-1999,共收集連續46位因原發性頰癌於本院接受完整同側術後輔助性放療(以電腦做治療計畫)之病人。通常以臨床上及術後電腦斷層上對側頸部正常者為接受同側放療之原則。共有43位男性及3位女性,中位年齡為52歲。多數病人為第三或第四期(41/46)。腫瘤床處之中位放療劑量為60格雷(範圍:50-70格雷)。 在中位追蹤20個月後(範圍:2-101個月)共有25個病人發生34處局部復發(同側:雙測:對側:其他=19:3:2:1)。期別(T4N2-3,4/11=36%)為最可能導致對側復發之危險因子。 除高危險性之頰癌病患外,術後輔助性放療可以治療同側為原則。 |
英文摘要 | To study the initial local regional relapse (iLRR) patterns following ipsilateral postoperative adjuvant radiotherapy (iPART) for primary buccal cancer as an aid in defining the clinical target volume (CTV) for buccal cancer. From June 1991 through April 1999, forty-six patients with localized primary squamous cell carcinoma of the buccal/gingival mucosa were treated with complete iPART with two dimensional (2D) planning technique (generally due to negative clinical/imaging exam of contralateral neck). The median age of these 43 men and 3 women was 58 years. Stage III/IV cases composed the majority of the study group (41/46). The median dose at tumor bed was 60 Gy with range of 50-70Gy. Eight patients received chemotherapy. After a median follow-up of 20 months (2-101 months), twenty-five patients had thirty-four iLRR (ipsilateral vs both side vs. contralateral only vs other = 19 vs. 3 vs. 2 vs. 1). Advanced stage (T4N2-3, 4/11 = 36%) was the most possible risk factor with statistical significance for contralateral iLRR. The risk of contralateral iLRR was 3% in non-T4N2-3 patients. It might be appropriate to perform iPART only for non high-risk buccal cancer patients. |
本系統中英文摘要資訊取自各篇刊載內容。